These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19928079)

  • 1. RBE estimation of proton radiation fields using a DeltaE-E telescope.
    Wroe A; Schulte R; Fazzi A; Pola A; Agosteo S; Rosenfeld A
    Med Phys; 2009 Oct; 36(10):4486-94. PubMed ID: 19928079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of proton pencil beam scanning and passive beam using a high spatial resolution solid-state microdosimeter.
    Tran LT; Chartier L; Bolst D; Pogossov A; Guatelli S; Petasecca M; Lerch MLF; Prokopovich DA; Reinhard MI; Clasie B; Depauw N; Kooy H; Flanz JB; McNamara A; Paganetti H; Beltran C; Furutani K; Perevertaylo VL; Jackson M; Rosenfeld AB
    Med Phys; 2017 Nov; 44(11):6085-6095. PubMed ID: 28887837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relative biological effectiveness for carbon, nitrogen, and oxygen ion beams using passive and scanning techniques evaluated with fully 3D silicon microdosimeters.
    Tran LT; Bolst D; Guatelli S; Pogossov A; Petasecca M; Lerch MLF; Chartier L; Prokopovich DA; Reinhard MI; Povoli M; Kok A; Perevertaylo VL; Matsufuji N; Kanai T; Jackson M; Rosenfeld AB
    Med Phys; 2018 May; 45(5):2299-2308. PubMed ID: 29572856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear interactions in proton therapy: dose and relative biological effect distributions originating from primary and secondary particles.
    Paganetti H
    Phys Med Biol; 2002 Mar; 47(5):747-64. PubMed ID: 11931469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in the RBE for cell killing along the depth-dose profile of a modulated proton therapy beam.
    Britten RA; Nazaryan V; Davis LK; Klein SB; Nichiporov D; Mendonca MS; Wolanski M; Nie X; George J; Keppel C
    Radiat Res; 2013 Jan; 179(1):21-8. PubMed ID: 23148508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calculation of relative biological effectiveness for proton beams using biological weighting functions.
    Paganetti H; Olko P; Kobus H; Becker R; Schmitz T; Waligorski MP; Filges D; Müller-Gärtner HW
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):719-29. PubMed ID: 9112472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microdosimetric calculation of relative biological effectiveness for design of therapeutic proton beams.
    Kase Y; Yamashita W; Matsufuji N; Takada K; Sakae T; Furusawa Y; Yamashita H; Murayama S
    J Radiat Res; 2013 May; 54(3):485-93. PubMed ID: 23179376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monte Carlo simulations of therapeutic proton beams for relative biological effectiveness of double-strand break.
    Wang CC; Hsiao Y; Lee CC; Chao TC; Wang CC; Tung CJ
    Int J Radiat Biol; 2012 Jan; 88(1-2):158-63. PubMed ID: 21823821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the physical and RBE-weighted dose estimator based on PHITS coupled with a microdosimetric kinetic model for proton therapy.
    Takada K; Sato T; Kumada H; Koketsu J; Takei H; Sakurai H; Sakae T
    J Radiat Res; 2018 Jan; 59(1):91-99. PubMed ID: 29087492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiobiological characterization of two therapeutic proton beams with different initial energy spectra used at the Institut Curie Proton Therapy Center in Orsay.
    Calugaru V; Nauraye C; Noël G; Giocanti N; Favaudon V; Mégnin-Chanet F
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1136-43. PubMed ID: 21075549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microdosimetric evaluation of secondary particles in a phantom produced by carbon 290 MeV/nucleon ions at HIMAC.
    Endo S; Takada M; Onizuka Y; Tanaka K; Maeda N; Ishikawa M; Miyahara N; Hayabuchi N; Shizuma K; Hoshi M
    J Radiat Res; 2007 Sep; 48(5):397-406. PubMed ID: 17690533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First experimental measurements of 2D microdosimetry maps in proton therapy.
    Guardiola C; Bachiller-Perea D; Kole EMM; Fleta C; Quirion D; De Marzi L; Gómez F
    Med Phys; 2023 Jan; 50(1):570-581. PubMed ID: 36066129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiobiological intercomparison of the 160 MeV and 230 MeV proton therapy beams at the Harvard Cyclotron Laboratory and at Massachusetts General Hospital.
    Wouters BG; Skarsgard LD; Gerweck LE; Carabe-Fernandez A; Wong M; Durand RE; Nielson D; Bussiere MR; Wagner M; Biggs P; Paganetti H; Suit HD
    Radiat Res; 2015 Feb; 183(2):174-87. PubMed ID: 25587741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance and implementation of RBE variations in proton beam therapy.
    Paganetti H
    Technol Cancer Res Treat; 2003 Oct; 2(5):413-26. PubMed ID: 14529306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microdosimetry of a therapeutic proton beam with a mini-TEPC and a MicroPlus-Bridge detector for RBE assessment.
    Conte V; Agosteo S; Bianchi A; Bolst D; Bortot D; Catalano R; Cirrone GAP; Colautti P; Cuttone G; Guatelli S; James B; Mazzucconi D; Rosenfeld AB; Selva A; Tran L; Petringa G
    Phys Med Biol; 2020 Dec; 65(24):245018. PubMed ID: 33086208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference in the relative biological effectiveness and DNA damage repair processes in response to proton beam therapy according to the positions of the spread out Bragg peak.
    Hojo H; Dohmae T; Hotta K; Kohno R; Motegi A; Yagishita A; Makinoshima H; Tsuchihara K; Akimoto T
    Radiat Oncol; 2017 Jul; 12(1):111. PubMed ID: 28673358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the dose-averaged LET a reliable predictor for the relative biological effectiveness?
    Grün R; Friedrich T; Traneus E; Scholz M
    Med Phys; 2019 Feb; 46(2):1064-1074. PubMed ID: 30565705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative biological effectiveness variation along monoenergetic and modulated Bragg peaks of a 62-MeV therapeutic proton beam: a preclinical assessment.
    Chaudhary P; Marshall TI; Perozziello FM; Manti L; Currell FJ; Hanton F; McMahon SJ; Kavanagh JN; Cirrone GA; Romano F; Prise KM; Schettino G
    Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):27-35. PubMed ID: 24986743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microdosimetric measurements as a tool to assess potential in-field and out-of-field toxicity regions in proton therapy.
    Missiaggia M; Cartechini G; Scifoni E; Rovituso M; Tommasino F; Verroi E; Durante M; La Tessa C
    Phys Med Biol; 2020 Dec; 65(24):245024. PubMed ID: 32554886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calculation of biological effectiveness of SOBP proton beams: a TOPAS Monte Carlo study.
    Chattaraj A; Selvam TP
    Biomed Phys Eng Express; 2024 Mar; 10(3):. PubMed ID: 38377599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.